Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Active not recruiting 6 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6 Tumor-Agnostic 3 Gastrointestinal 2 Plasma cell 1 Lymphoid 1 Dermatologic 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 174 Rituximab 146 venetoclax 82 Specimen Handling 81 fludarabine 80 Vincristine 69 obinutuzumab 68 Prednisone 66 Doxorubicin 66 Biopsy 63 Magnetic Resonance Spectroscopy 62 Lenalidomide 54 zanubrutinib 52 Dexamethasone 48 Cytarabine 44 Methotrexate 43 blinatumomab 41 Immunotherapy, Adoptive 40 acalabrutinib 37 Bendamustine Hydrochloride 37 fludarabine phosphate 32 Etoposide 32 ibrutinib 30 polatuzumab vedotin 27 glofitamab 27 pirtobrutinib 25 orelabrutinib 25 Gemcitabine 24 Injections 21 Mercaptopurine 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Crizotinib × Lymphoid × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡